Rajesh Asija*, Manmohan Sharma, Avinash Gupta, Sangeeta Asija Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Jaipur-302020, Rajasthan, India Received: 21 April 2014, Accepted: 21 June 2014, Published Online: 10 August 2014 Abstract Zolmitriptan is a selective serotonin receptor agonist of the 5HT1B and 5HT1D subtypes, both centrally and peripherally. It has been used clinically for the acute treatment of ... Read More »